Showing results (111-120 of 221) with videos related to

Sort By:
Pageof 23
Gastroenterology|February 14, 2006
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trialStephen B Hanauer, William J Sandborn, Paul Rutgeerts, et al.
The New England Journal of Medicine|July 20, 2007
Maintenance therapy with certolizumab pegol for Crohn's diseaseStefan Schreiber, Mani Khaliq-Kareemi, Ian C Lawrance, et al.
Inflammatory Bowel Diseases|December 15, 2015
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade DysplasiaNoa Krugliak Cleveland, Ruben J Colman, Dylan Rodriquez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 17, 2013
Treat to target: a proposed new paradigm for the management of Crohn's diseaseGuillaume Bouguen, Barrett G Levesque, Brian G Feagan, et al.
Alcoholism, Clinical and Experimental Research|September 3, 2015
Chronic Alcohol Exposure and the Circadian Clock Mutation Exert Tissue-Specific Effects on Gene Expression in Mouse Hippocampus, Liver, and Proximal ColonKeith C Summa, Peng Jiang, Karrie Fitzpatrick, et al.
Inflammatory Bowel Diseases|March 9, 2007
Smoking and inflammatory bowel disease: trends in familial and sporadic cohortsJeffrey A Tuvlin, Sania S Raza, Samuel Bracamonte, et al.
Alcoholism, Clinical and Experimental Research|February 5, 2016
The Circadian Clock Mutation Promotes Intestinal DysbiosisRobin M Voigt, Keith C Summa, Christopher B Forsyth, et al.
The American Journal of Gastroenterology|November 11, 2005
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trialStephen B Hanauer, William J Sandborn, Asher Kornbluth, et al.
Frontiers in Pharmacology|October 31, 2022
Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosaLaura D Manzanares, Joseph David, Xingsheng Ren, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2015
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future DirectionsLaurent Peyrin-Biroulet, Julián Panés, William J Sandborn, et al.
Pageof 23